FR2804962B1 - PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES - Google Patents

PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES

Info

Publication number
FR2804962B1
FR2804962B1 FR0001628A FR0001628A FR2804962B1 FR 2804962 B1 FR2804962 B1 FR 2804962B1 FR 0001628 A FR0001628 A FR 0001628A FR 0001628 A FR0001628 A FR 0001628A FR 2804962 B1 FR2804962 B1 FR 2804962B1
Authority
FR
France
Prior art keywords
partners
preparation
ptb1 domain
ptb1
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0001628A
Other languages
French (fr)
Other versions
FR2804962A1 (en
Inventor
Isabelle Maury
Luc Mercken
Alain Fournier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0001628A priority Critical patent/FR2804962B1/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to KR1020027010351A priority patent/KR100802687B1/en
Priority to AT01907727T priority patent/ATE415476T1/en
Priority to AU3562501A priority patent/AU3562501A/en
Priority to DK01907727T priority patent/DK1257642T3/en
Priority to BR0108247-7A priority patent/BR0108247A/en
Priority to DE60136688T priority patent/DE60136688D1/en
Priority to JP2001558242A priority patent/JP4745583B2/en
Priority to IL15114701A priority patent/IL151147A0/en
Priority to CA002399939A priority patent/CA2399939A1/en
Priority to EP01907727A priority patent/EP1257642B1/en
Priority to NZ520697A priority patent/NZ520697A/en
Priority to ES01907727T priority patent/ES2315273T3/en
Priority to PCT/FR2001/000361 priority patent/WO2001059104A1/en
Priority to PT01907727T priority patent/PT1257642E/en
Priority to AU2001235625A priority patent/AU2001235625B2/en
Priority to MXPA02007620A priority patent/MXPA02007620A/en
Priority to US09/780,996 priority patent/US6696273B2/en
Publication of FR2804962A1 publication Critical patent/FR2804962A1/en
Priority to ZA200206317A priority patent/ZA200206317B/en
Priority to NO20023783A priority patent/NO330798B1/en
Priority to US10/726,721 priority patent/US6942982B2/en
Publication of FR2804962B1 publication Critical patent/FR2804962B1/en
Application granted granted Critical
Priority to CY20091100140T priority patent/CY1108758T1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0001628A 2000-02-10 2000-02-10 PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES Expired - Fee Related FR2804962B1 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
FR0001628A FR2804962B1 (en) 2000-02-10 2000-02-10 PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES
PT01907727T PT1257642E (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses
AT01907727T ATE415476T1 (en) 2000-02-10 2001-02-07 PARTNERS OF THE PTB1 DOMAIN FROM FE65, PRODUCTION AND USES THEREOF
AU2001235625A AU2001235625B2 (en) 2000-02-10 2001-02-07 Partners of PTB1 domain of FE65, preparation and uses
BR0108247-7A BR0108247A (en) 2000-02-10 2001-02-07 Compound, polypeptide, nucleic acid, vector, defective recombinant virus, antibody or antibody fragment or derivative, pharmaceutical composition, processes for the screening or characterization of active molecules and for the production of a peptide compound
DE60136688T DE60136688D1 (en) 2000-02-10 2001-02-07 PARTNERS OF PTB1 DOME FROM FE65, MANUFACTURE AND USES THEREOF
JP2001558242A JP4745583B2 (en) 2000-02-10 2001-02-07 Partner, manufacture and use of PTB1 domain of FEB65
IL15114701A IL151147A0 (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses
CA002399939A CA2399939A1 (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses
EP01907727A EP1257642B1 (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses
NZ520697A NZ520697A (en) 2000-02-10 2001-02-07 Partners of PTB1 domain of FE65, preparation and uses
ES01907727T ES2315273T3 (en) 2000-02-10 2001-02-07 COUPLES OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USE.
KR1020027010351A KR100802687B1 (en) 2000-02-10 2001-02-07 Partners of the ptb1 domain of fe65, preparation and uses
AU3562501A AU3562501A (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses
DK01907727T DK1257642T3 (en) 2000-02-10 2001-02-07 Partners for the PTB1 domain of FE65, manufacturing and applications
MXPA02007620A MXPA02007620A (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses.
PCT/FR2001/000361 WO2001059104A1 (en) 2000-02-10 2001-02-07 Partners of ptb1 domain of fe65, preparation and uses
US09/780,996 US6696273B2 (en) 2000-02-10 2001-02-09 FEBP1 Protein: vector, host cells and method for making FEBP1 protein
ZA200206317A ZA200206317B (en) 2000-02-10 2002-08-07 Partners of PTB1 domain of FE65, preparation and uses.
NO20023783A NO330798B1 (en) 2000-02-10 2002-08-09 Polypeptide, nucleic acid, vector, virus, antibody, pharmaceutical preparation and method of preparation and screening
US10/726,721 US6942982B2 (en) 2000-02-10 2003-12-03 FEBP1 protein vector host cells and method for making FEBP1 protein
CY20091100140T CY1108758T1 (en) 2000-02-10 2009-02-05 FE65 SECTOR RTV1 ASSOCIATED PARTICIPANTS, PREPARATION AND USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001628A FR2804962B1 (en) 2000-02-10 2000-02-10 PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES

Publications (2)

Publication Number Publication Date
FR2804962A1 FR2804962A1 (en) 2001-08-17
FR2804962B1 true FR2804962B1 (en) 2005-02-25

Family

ID=8846829

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0001628A Expired - Fee Related FR2804962B1 (en) 2000-02-10 2000-02-10 PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES

Country Status (3)

Country Link
JP (1) JP4745583B2 (en)
FR (1) FR2804962B1 (en)
ZA (1) ZA200206317B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2311683A1 (en) * 1997-11-26 1999-06-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6214582B1 (en) * 1998-11-16 2001-04-10 The Research Foundation Of State University Of Ny Y2H35 a strong IKK binding protein
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2002543785A (en) * 1999-05-11 2002-12-24 インサイト・ゲノミックス・インコーポレイテッド Extracellular matrix and adhesion-related proteins

Also Published As

Publication number Publication date
JP2003521944A (en) 2003-07-22
JP4745583B2 (en) 2011-08-10
ZA200206317B (en) 2003-11-07
FR2804962A1 (en) 2001-08-17

Similar Documents

Publication Publication Date Title
FR14C0064I2 (en) ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND RELATED USES
BR0100925B1 (en) set of panels and joining elements.
ID28787A (en) SUBSTITUTED 2-PHENILBENZIMIDAZOL, ITS MAKING AND USE OF IT
DE60115683D1 (en) BIOSTABILE SMALL INTRODUCTION
FR2785543B1 (en) MODIFIED EXOSOMES AND USES
ID30139A (en) COMPLEX OF RAS-FARNESILTRANSFERASE AND SULFOBUTILETER-7- INHIBITORS OR CYCLODEXTRINS OR 2-HYDROXYXYOPROPYL--SICLODODSTRINTS AND ITS METHODS
DE50112013D1 (en) DEODORANTIA AND ANTIPERSPIRANTIES
NO20023573D0 (en) True relative amplitude migration
FI20012426A0 (en) Composite nonwoven, its use and the method of making it
DE60229819D1 (en) Powertrain and its assembly method
ID30187A (en) DONGKRAK KIND OF PANTAGRAF
DE50015396D1 (en) DYNAMIC SEAL
DE60125961D1 (en) MODULATION OF THE ALLERGIC ANSWER
DE60121132D1 (en) FULL-LOCKING MOMENT-DEPENDENT DIFFERENTIAL
DE29809075U1 (en) Dynamic, display-like piece of jewelry
BR0108075B1 (en) fabric softening composition, and use of an aqueous dispersion.
FR2819411B1 (en) IRIDESCENT COSMETIC COMPOSITION AND USES THEREOF
EE200100622A (en) The process of increasing the value of natural hydrocarbon resources
ID30462A (en) CONDENSER AND ES CABINET
BR0115856B1 (en) bituminous composition, and, use of composition.
FR2819412B1 (en) IRIDESCENT COSMETIC COMPOSITION AND USES THEREOF
FR2804962B1 (en) PARTNERS OF THE PTB1 DOMAIN OF FE65, PREPARATION AND USES
ATE317386T1 (en) DIHYDROINDOLE AND TETRAHYDROCINOLINE DERIVATIVES
NO20030663D0 (en) Cardboard and insert, as well as subject for formation of the same
FI19992142A (en) Water-needled nonwovens, the method of their manufacture and their use

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121031